Pharmacological Evaluation of Metal–Organic Frameworks (MOFs): Emerging Nanocarriers in Modern Pharmaceutics
Indian Journal of Pharmaceutical Chemistry and Analytical Techniques · 25.02.2026 · 35-44
DOI: 10.64062/ijpcat.vol2.issue1.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pharmaceutical Chemistry and Analytical Techniques, online erschienen am 25.02.2026. Verfasst von Harsh Tamrakar Tamrakar und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Metal–organic frameworks (MOFs) have emerged as powerful next-generation nanocarriers in modern pharmaceutics, offering unique advantages over conventional delivery systems through their exceptional porosity, tunability, and modular architecture. This review provides a comprehensive evaluation of MOF-based drug delivery platforms, emphasizing their structural fundamentals, synthesis strategies, drug-loading mechanisms, pharmacokinetics, and therapeutic potential. Pharmaceutical-grade MOFs are now engineered through advanced solvothermal, microwave-assisted, mechanochemical, and microfluidic methods, supported by green chemistry innovations and precise post-synthetic modifications. Their versatile loading mechanisms accommodate small-molecule drugs, biomacromolecules, and nucleic acids, while physicochemical attributes—such as pore size, surface chemistry, and degradability—dictate in vivo biodistribution and release kinetics. MOFs demonstrated significant pharmacological applications in cancer therapy, antimicrobial and antiviral treatment, gene delivery, gas storage, and enzyme-based therapeutics. However, concerns regarding cytotoxicity, degradation products, immunogenicity, and long-term accumulation highlight the importance of rigorous toxicological evaluation and biosafety-focused design. Emerging trends—including biomimetic coatings, MOF–polymer hybrids, stimuli-responsive systems, AI-guided design, and theranostic platforms—are rapidly advancing their clinical relevance. Despite ongoing challenges related to scalability, reproducibility, and regulatory approval, MOF nanocarriers hold strong potential to revolutionize personalized and precision medicine through smart, adaptable, and multifunctional therapeutic delivery systems
Zitieren
APA
Tamrakar, H. T., Jain, T. K. J., Singh, N. S., Kumar, D. K., & Verma, V. S. V. (2026). Pharmacological Evaluation of Metal–Organic Frameworks (MOFs): Emerging Nanocarriers in Modern Pharmaceutics. Indian Journal of Pharmaceutical Chemistry and Analytical Techniques, 35-44. https://doi.org/10.64062/ijpcat.vol2.issue1.4
Vancouver
Tamrakar HT, Jain TKJ, Singh NS, Kumar DK, Verma VSV. Pharmacological Evaluation of Metal–Organic Frameworks (MOFs): Emerging Nanocarriers in Modern Pharmaceutics. Indian Journal of Pharmaceutical Chemistry and Analytical Techniques. 2026:35-44. doi:10.64062/ijpcat.vol2.issue1.4
BibTeX
@article{Tamrakar2026,
author = {Tamrakar, Harsh Tamrakar and Jain, Tarun Kumar Jain and Singh, Nikita Singh and Kumar, Deleshwar Kumar and Verma, Vinay Sagar Verma},
title = {Pharmacological Evaluation of Metal–Organic Frameworks (MOFs): Emerging Nanocarriers in Modern Pharmaceutics},
journal = {Indian Journal of Pharmaceutical Chemistry and Analytical Techniques},
year = {2026},
pages = {35--44},
doi = {10.64062/ijpcat.vol2.issue1.4}
}
EUVIMED